Indication
Chemotherapy-Induced Nausea and Vomiting
3 clinical trials
3 products
Product
AkynzeoClinical trial
Akynzeo or Olanzapine for Patients Who Experience Breakthrough CINV in Patient Receiving Moderately or Highly Emetogenic Chemotherapy After First Cycle of ChemotherapyStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Phase IV, Real World Observational Study On The Use Of Akynzeo® (Netupitant/Palonosetron) For The Prevention Of Nausea and Vomiting in Oncology Patients Receiving Highly Emetogenic Chemotherapy (HEC) Over Multiple Cycles.Status: Completed, Estimated PCD: 2019-12-30
Clinical trial
An Open-label, Cross-over, Pharmacokinetic Study to Assess the Safety and Pharmacokinetics of Transdermal Granisetron (Sancuso® Patch) and IV Granisetron in a Pediatric Oncology Population (Aged 13 to 17 Years)Status: Completed, Estimated PCD: 2015-08-01
Product
Granisetron